bioGLOT Ventures Invites Investors to Invest in ABL Biotec venture
bioGLOT Ventures invites Spin-off and Start-up teams that seek Financing to apply for Free Consultation
bioGLOT Ventures introduces DIAMS iQ - IP management software by Dennemeyer IP Group
Let's talk how we may be of your assistance
Note that Products, Services & Solutions listed below are supported
by bioGLOT Ventures in Greece and Cyprus
Hello first name
We are reaching the 2,000 recipients for our Newsletter and we wish to thank all those who share their thoughts, especially on Linked in, and find our model and services interesting and compelling.
It is our intention to soon move to more customised Newsletters for different groups with similar interests.
In this edition we primarily deal with start-up financing and more specifically, of the Biomed sector. Health tech venture-backed investments continued strong in 2019, hitting a record according to a report by Silicon Valley Bank (SVB).
We at bioGLOT Ventures are appealing to
the Investors world to discuss about financing Biomed (and other) projects
the Start-up community to share their venture plans and apply for free Consultation and support
We also present DIAMS iQ ― IP management software by Dennemeyer IP Group
bioGLOT Ventures Invites Investors to Invest in ABL Biotec Venture
Anastasis Biotec Ltd (ABL) is a pre-clinical-stage biopharmaceutical company focused on developing innovative oncology therapeutics that target cancers depended on rogue cells multiplying uncontrollably caused by DNA abnormalities (mutations) in important pathways involved in the generation of cancer and cancer stem cells.
Anastasis Biotec is developing a novel and proprietary treatment; tailor made for patients with cancers that express specific ‘cancer driving mutations’. This treatment, by targeting specific and critical mutations, could potentially provide a breakthrough in the treatment of cancer types with significant clinical unmet need.
ABL Inventor and CEO, Greek-Cypriot Dr Agamemnon Epenetos, PhD, FRCP has been a practising Oncologist and Cancer Researcher over the last 30 years. He was, until recently, a visiting Professor at Imperial College London and has published widely on novel cancer therapies receiving much international recognition. Dr Epenetos has an impressive portfolio of patents and a pipeline of novel drug candidates.
bioGLOT Ventures invitesSpin-off and Start-upteams that seek Financingto apply forFree Consultation
As we have informed you in a previous Newsletter of ours, for every business we undertake to secure financing we will support a new one with free consultation.
In bioGLOT Ventures we welcome the opportunity to discuss how we can assist your Venture and we invite Spin-offs / Start-ups, especially in the Bio-med sector, to submit their Venture Plans for assessment to bioGLOT Ventures
How we can assist you
Raising money for your start-up can be like navigating through the Amazon by the stars. With our assistance we will help you to
Do a financial model that actually makes sense
Do a decent pitch deck
Build your narrative you tell investors
Understand your strategy and ensure you have a clear focus in execution between milestones
Comprehend your key metrics to communicate
Figure out which investors to pitch and ensure you connect with them the right way
bioGLOT VenturesintroducesDIAMS iQ - IP management software by Dennemeyer IP Group
DIAMS iQ is Dennemeyer’s state of the art IP management software is ideal for IP professionals who have a portfolio with an increasing number of IP rights that requires constant supervision, control at your fingertips, and a high level of cost transparency.
This web-enabled Intellectual Property asset management system combines the most valuable features of both a client-server solution and a web-based application.
With integrated document and workflow management functionality, DIAMS iQ has a multitude of IP management tools that support all of your electronic record-keeping needs.
Combined with other patent related services such as Patent Annuities or Patent Prosecution, DIAMS iQ covers the entire bandwidth of your IP portfolio.
